文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

高渗高血糖综合征住院患者急性肾损伤的发生、相关因素及院内结局:2013-2022年全国住院患者样本回顾性分析

Occurrence, Associated Factors, and In-Hospital Outcomes of Acute Kidney Injury in Patients Hospitalized with Hyperosmolar Hyperglycemic State: A Retrospective Analysis of the Nationwide Inpatient Sample (2013-2022).
PubMed 文献 · Shock · 2026-08-20
一句话结论HHS住院患者中56.1%发生AKI,AKI与更高院内死亡(4.6% vs 1.3%)、透析和机械通气使用及更长住院时间相关。

该回顾性队列研究基于美国全国住院患者样本(Nationwide Inpatient Sample),纳入2013-2022年80,557例HHS住院患者,采用ICD诊断编码识别AKI,并通过多因素logistic回归评估人口学、机构、合并症及并发症因素与AKI的关联。结果显示56.1%的患者发生AKI,且发生率从2013年的45.9%上升至2022年的63.6%。AKI与更差临床结局显著相关,包括更长中位住院时间(4 vs 3天)、更高总费用($35,026 vs $24,279)、更高院内死亡率(4.6% vs 1.3%)以及透析(1.3% vs 0.1%)和机械通气(4.2% vs 2.0%)使用增加(P<0.001)。

要点

  • 在80,557例HHS住院患者中,56.1%发生AKI,发生率从2013年45.9%升至2022年63.6%。
  • AKI与院内死亡率升高相关(4.6% vs 1.3%,P<0.001),并增加透析(1.3% vs 0.1%)和机械通气(4.2% vs 2.0%)使用。
  • AKI患者中位住院时间更长(4 vs 3天),总费用更高($35,026 vs $24,279)。
  • 独立预测因素包括高龄、Black或Asian/Pacific Islander种族、大型或教学医院、南部或西部地理区域。
  • 合并症中,缺铁性贫血、凝血障碍、伴慢性并发症的糖尿病、心力衰竭、高血压、水电解质紊乱、其他神经系统疾病、瘫痪、慢性肾脏病(除外终末期肾病)和急性胰腺炎与AKI风险增加显著相关。

适用人群与场景

  • 2013-2022年美国全国住院患者样本中80,557例HHS住院患者。

诊断标准与关键阈值

  • AKI通过ICD诊断编码识别。
  • 原文未提及HHS诊断标准或AKI分期标准。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 回顾性队列研究,基于美国全国住院患者样本,纳入2013-2022年80,557例HHS住院患者,采用ICD编码识别AKI,多因素logistic回归评估相关因素。
  • AKI发生率为56.1%(45,202例),从2013年45.9%上升至2022年63.6%。
  • 独立预测因素包括高龄、Black或Asian/Pacific Islander种族、大型或教学医院、南部或西部地理区域。
  • 合并症中,缺铁性贫血、凝血障碍、伴慢性并发症的糖尿病、心力衰竭、高血压、水电解质紊乱、其他神经系统疾病、瘫痪、慢性肾脏病(除外终末期肾病)和急性胰腺炎与AKI风险增加显著相关。
  • AKI与更长中位住院时间(4 vs 3天)、更高总费用($35,026 vs $24,279)、更高院内死亡率(4.6% vs 1.3%)、更多透析(1.3% vs 0.1%)和机械通气(4.2% vs 2.0%)使用相关(P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未明确提及,但设计本身为回顾性、基于行政数据库、使用ICD编码识别AKI,可能存在编码偏倚和未测量混杂。

对床旁实践的改变

  • 提示急诊/ICU医生对HHS住院患者应早期识别AKI,尤其在高龄、Black或Asian/Pacific Islander种族、合并缺铁性贫血、凝血障碍、伴慢性并发症的糖尿病、心力衰竭、高血压、水电解质紊乱、其他神经系统疾病、瘫痪、慢性肾脏病(除外终末期肾病)或急性胰腺炎的患者中。
  • AKI与更高院内死亡、透析和机械通气使用相关,应加强监测和干预。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Hyperosmolar hyperglycemic state (HHS) is a serious hyperglycemic emergency frequently complicated by acute kidney injury (AKI). However, large-scale national data on AKI occurrence, associated factors, and in-hospital outcomes in HHS patients remain lacking.

METHODS: We performed a retrospective cohort study of 80,557 U.S. hospitalizations for hyperosmolar hyperglycemic state (HHS) between 2013 and 2022, using data from the Nationwide Inpatient Sample. Acute kidney injury (AKI) was identified using ICD diagnosis codes, and associations with demographic, institutional, comorbid, and complication-related factors were assessed through multivariable logistic regression.

RESULTS: Within this cohort, 45,202 individuals (56.1%) had documented AKI, with its occurrence increasing from 45.9% in 2013 to 63.6% in 2022. Independent predictors encompassed advanced age, Black or Asian/Pacific Islander race, affiliation with large or teaching hospitals, and geographic location in the South or West. Several comorbidities were significantly associated with increased AKI risk, including deficiency anemia, coagulopathy, diabetes with chronic complications, heart failure, hypertension, fluid and electrolyte disorders, other neurological disorders, paralysis, chronic kidney disease excluding end-stage renal disease and acute pancreatitis. AKI was significantly associated with worse clinical outcomes, manifested as longer median hospital stay (4 vs. 3 days), higher total charges ($35,026 vs. $24,279), greater in-hospital mortality (4.6% vs. 1.3%), and increased utilization of dialysis (1.3% vs. 0.1%) and mechanical ventilation (4.2% vs. 2.0%) (P<0.001).

CONCLUSION: AKI was common among HHS patients and associated with increased mortality and healthcare costs, underscoring the importance of early recognition and targeted intervention.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lin P, Chen Y, Peng Y, et al. Occurrence, Associated Factors, and In-Hospital Outcomes of Acute Kidney Injury in Patients Hospitalized with Hyperosmolar Hyperglycemic State: A Retrospective Analysis of the Nationwide Inpatient Sample (2013-2022). Shock. 2026. PMID: 42619455. doi:10.1097/SHK.0000000000002923

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。